Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

209 Views

Poster Session: PK/PD Studies

614 - Pharmacodynamics (PD) of the Beta-Lactamase Inhibitor Xeruborbactam When Administered as the Oral Prodrug in Combination with Ceftibuten

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Ziad Tarazi

Scientist
The Medicines Company, San Diego LLC c/o Qpex Biopharma, Inc.
San Diego, California, United States

Co-Author(s)

NR

Niki Roos, n/a

Research Associate
Qpex Biopharma
San Diego, California, United States
TP

Ted Page, n/a

Principal Investigator, Pharmacology
Qpex Biopharma
San Diego, California, United States
DG

David Griffith, n/a

Sr. Vice-President, Non-Clinical and Clinical Development
Qpex Biopharma
San Diego, California, United States